Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2010-3-26
pubmed:abstractText
The aim was to determine the values of p53 tumour expression and microsatellite instability (MSI) phenotype to predict benefit from adjuvant chemotherapy of colon cancer by 5-fluorouracil and leucovorin (FL) alone or with oxaliplatin (FOLFOX).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1569-8041
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
772-80
pubmed:meshHeading
pubmed-meshheading:19833818-Adenocarcinoma, pubmed-meshheading:19833818-Adult, pubmed-meshheading:19833818-Aged, pubmed-meshheading:19833818-Aged, 80 and over, pubmed-meshheading:19833818-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:19833818-Colonic Neoplasms, pubmed-meshheading:19833818-Disease-Free Survival, pubmed-meshheading:19833818-Female, pubmed-meshheading:19833818-Fluorouracil, pubmed-meshheading:19833818-Humans, pubmed-meshheading:19833818-Leucovorin, pubmed-meshheading:19833818-Male, pubmed-meshheading:19833818-Microsatellite Instability, pubmed-meshheading:19833818-Middle Aged, pubmed-meshheading:19833818-Neoplasm Staging, pubmed-meshheading:19833818-Organoplatinum Compounds, pubmed-meshheading:19833818-Retrospective Studies, pubmed-meshheading:19833818-Tumor Suppressor Protein p53
pubmed:year
2010
pubmed:articleTitle
Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.
pubmed:affiliation
INSERM, UMR_S 938, Saint-Antoine Research Centre, 184 rue du Faubourg Saint-Antoine, Paris cedex 12, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies